Bioserve Biotechnologies Partners with BioMavericks Ltd. to Expand Presence in the UK market
27 September 2023
[Hyderabad, India, 27 September 2023] – Bioserve Biotechnologies (India) Pvt Limited, is teaming up with BioMavericks Ltd., a UK-based company.
Bioserve India to sponsor webinar hosted by the Society of Fetal Medicine
15 September 2021
Find out more about Genetic Testing in Fetal Medicine in the upcoming REPROCELL sponsored webinar by the Society of Fetal Medicine.
REPROCELL and Hanugen to custom manufacture clinical grade oligos for gene therapy
24 April 2019
REPROCELL India and Hanugen Therapeutics have announced the launch of their custom manufacture offering for synthesis of milli molar scale clinical grade oligonucleotides for gene therapy.
REPROCELL USA Inc. Achieves Quality Management ISO9001:2015 Certification
08 April 2019
Find out about REPROCELL USA's recently achieved ISO9001:2015 accreditation. demonstrating its ability to consistently meet customer requirements
REPROCELL’s footprint extends to serve life sciences in India
13 June 2018
Learn more about REPROCELL India's expansion into the life sciences industry through the integration of Oligonucleotide Services and Next Generation Sequencing
Acquisition of BioServe Biotechnologies India Pvt. Ltd.
26 April 2018
REPROCELL announces that it has acquired Bioserve biotechnologies, further expanding REPROCELL's portfolio of service offerings